Pushpamali De Silva Department : Molecular Immunology Laboratory Pushpamali.DeSilva [at] bordet.be Publications Targeting CTLA-4 in cancer: Is it the ideal companion for PD-1 blockade immunotherapy combinations? Authors : De Silva P, Aiello M, Gu-Trantien C, Migliori E, Willard-Gallo K, Solinas C Year : 2020 Journal : Int J Cancer Homologous Recombination Repair Deficiency and the Immune Response in Breast Cancer: A Literature Review. Authors : Pellegrino B, Musolino A, Llop-Guevara A, Serra V, De Silva P, Hlavata Z, Sangiolo D, Willard-Gallo K, Solinas C Year : 2020 Journal : Transl Oncol Significance of TIM3 expression in cancer: From biology to the clinic. Authors : Solinas C, De Silva P, Bron D, Willard-Gallo K, Sangiolo D Year : 2019 Journal : Semin Oncol LAG3: The Biological Processes That Motivate Targeting This Immune Checkpoint Molecule in Human Cancer. Authors : Solinas C, Migliori E, De Silva P, Willard-Gallo K Year : 2019 Journal : Cancers (Basel) Targeting PD-1 in cancer: Biological insights with a focus on breast cancer. Authors : Solinas C, Aiello M, De Silva P, Gu-Trantien C, Migliori E, Willard-Gallo K Year : 2019 Journal : Crit Rev Oncol Hematol More publications »